I like the excitement of NP. I think he can keep the excitement and still manage expectations. You do that by hitting milestones earlier than predicted. I know it is hard with the FDA moving the goal post. But for example with partnerships, if he had said last year, there are several opportunists, we are going to work over the next year to determine the best one. Our goal is to have a deal signed before drug approval. We don't want to jump into any deal too early, we don't want to accept the current offers; we feel if we dilute a little more over the next year while we submit the BLA and get approval, we can get better terms through negotiation. They he could give updates on the progress and still be excited about it.